Help keep Brustkrebs-Kompass free
Last updated: 16 July 2026
Brustkrebs-Kompass is a free app for women with breast cancer. It is and remains 100 % free: no advertising, no tracking, no data selling. All personal data stays on the user's own device.
To make that possible, real costs still come first, before the app can enter the app stores and while it runs: legal and MDR classification by a specialist lawyer, the developer accounts at Apple and Google, hosting, and ongoing maintenance. The app is built single- handedly, without an investor and without a paywall. Every contribution goes directly into these costs.
How you can support
Support is currently paused
Transition in progressThe organisational structure behind Brustkrebs-Kompass is currently being restructured. To make sure every contribution reaches the correct recipient cleanly from day one, the payment channels are paused until the new structure is in place. Until then I deliberately do not accept any payments.
Once the transition is complete, all ways to support the project will be available here again. If you would like to be notified, write to team@brustkrebs-kompass.de.
Support without money
While the payment channels are paused, visibility helps most. For practices, clinics, counselling services and support groups there is a ready-made notice block to embed on your own site. It is fully styled, loads nothing from outside and sets no cookies.
View the notice card and copy the code
What your contribution funds
Stage 1 · Goal: 8,000 €
Clearing the starting hurdle. So the app can enter the app stores officially and on solid legal ground.
- Specialist lawyer for MDR classification (written assessment: medical device yes or no)
- Developer accounts at Apple and Google (year 1)
- Hosting, domain, Supabase (year 1)
- Small reserve for unforeseen items
Stage 2 · Stretch goal: 30,000 €
Only if required. If the lawyer's review concludes the app is classified as a Class I medical device.
- Technical documentation and risk management per ISO 14971
- CE conformity assessment so the app can operate as a certified medical device in the EU
- Clinical evaluation of the content
Then · International
Once the EU hurdle is cleared, the UK (MHRA) and Switzerland (Swissmedic) come next with similar requirements, later the US. That stage is funded from ongoing support, plus translation editing into further languages.
What does not happen
- No advertising, no data sales. No funder influences our content or assessments.
- No data sharing with health insurers, research or advertisers
- No hidden premium features
- No affiliate commissions for recommendations
- No sale to an investor with return expectations
Questions or larger sponsorship partnership
Email: team@brustkrebs-kompass.de
If a non-profit organisation is interested in patronage or sponsorship partnership, we welcome contact.